124 related articles for article (PubMed ID: 34699702)
21. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
22. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.
Palmert MR; Gordon CM; Kartashov AI; Legro RS; Emans SJ; Dunaif A
J Clin Endocrinol Metab; 2002 Mar; 87(3):1017-23. PubMed ID: 11889155
[TBL] [Abstract][Full Text] [Related]
23. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
25. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
Chen X; Yang D; Li L; Feng S; Wang L
Hum Reprod; 2006 Aug; 21(8):2027-32. PubMed ID: 16684838
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.
Capula C; Chiefari E; Vero A; Foti DP; Brunetti A; Vero R
Diabetes Res Clin Pract; 2014 Aug; 105(2):223-30. PubMed ID: 24931701
[TBL] [Abstract][Full Text] [Related]
27. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.
Kakoly NS; Khomami MB; Joham AE; Cooray SD; Misso ML; Norman RJ; Harrison CL; Ranasinha S; Teede HJ; Moran LJ
Hum Reprod Update; 2018 Jul; 24(4):455-467. PubMed ID: 29590375
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome.
Espinós-Gómez JJ; Corcoy R; Calaf J
Gynecol Endocrinol; 2009 Mar; 25(3):199-204. PubMed ID: 19347711
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing dysglycemia in adolescents with polycystic ovary syndrome.
Gooding HC; Milliren C; St Paul M; Mansfield MJ; DiVasta A
J Adolesc Health; 2014 Jul; 55(1):79-84. PubMed ID: 24560306
[TBL] [Abstract][Full Text] [Related]
31. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
32. Impaired glucose metabolism in women with polycystic ovary syndrome.
Vrbikova J; Fanta M; Cibula D; Vondra K; Bendlova B
Gynecol Obstet Invest; 2009; 68(3):186-90. PubMed ID: 19672087
[TBL] [Abstract][Full Text] [Related]
33. Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.
Amato MC; Magistro A; Gambino G; Vesco R; Giordano C
Eur J Endocrinol; 2015 Jan; 172(1):79-88. PubMed ID: 25342852
[TBL] [Abstract][Full Text] [Related]
34. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
[TBL] [Abstract][Full Text] [Related]
35. Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome.
Coles N; Bremer K; Kives S; Zhao X; Hamilton J
J Pediatr Adolesc Gynecol; 2016 Feb; 29(1):48-52. PubMed ID: 26358939
[TBL] [Abstract][Full Text] [Related]
36. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
37. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.
Larsson H; Ahrén B
Diabetes Care; 1996 Dec; 19(12):1399-403. PubMed ID: 8941471
[TBL] [Abstract][Full Text] [Related]
38. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.
Legro RS; Gnatuk CL; Kunselman AR; Dunaif A
J Clin Endocrinol Metab; 2005 Jun; 90(6):3236-42. PubMed ID: 15797965
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
40. [Characteristics of glucose metabolism in non-obese and obese women with polycystic ovarian syndrome].
Shi YH; Zhao DN; Zhao JL; You L; Liu H; Sun M; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):575-7. PubMed ID: 21029611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
